FENG [Phoenix New Media] F-X:
[]
[Execution Version CONSORTIUM AGREEMENT CONSORTIUM AGREEMENT Agreement This Ocean Management Ctrip Party Parties Section 10.1 WHEREAS Consortium Transaction Target NASDAQ Exchange Act WHEREAS Proposal Target Board WHEREAS Parent Merger Sub Closing Surviving Company WHEREAS Merger Agreement NOW THEREF]
[] [See Risk Factors for a discussion of risks that you should consider before participating in this Exchange Offer. You should have received the following documents along with this document: · · · If you have not received any of these documents or need another copy, please contact Ms. Xiong Na, 2 ]
[Execution Version CONSORTIUM AGREEMENT CONSORTIUM AGREEMENT Agreement This Ocean Management Ctrip Party Parties Section 10.1 WHEREAS Consortium Transaction Target NASDAQ Exchange Act WHEREAS Proposal Target Board WHEREAS Parent Merger Sub Closing Surviving Company WHEREAS Merger Agreement NOW THEREF]
[] [See Risk Factors for a discussion of risks that you should consider before participating in this Exchange Offer. You should have received the following documents along with this document: · · · If you have not received any of these documents or need another copy, please contact Ms. Xiong Na, 2 ]
[Page 1.1 Announcement, dated October 20, 2016 A-1 our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; our operations and prospects; our network expansion and capital expenditure plans; the expected impact ]
[STIFEL Rule 10b5-1 Individual Purchase Plan ISSUER NAME LightInTheBox Holding Co Ltd TICKER SYMBOL LITB PURCHASER NAME Zall Development (HK) Holding Company Limited PLAN ACCOUNT NUMBER FA NAME PLAN EXECUTION DATE 9 September 2016 PLAN TYPE Individual Purchase PLAN BEGINNING DATE [***] PLAN TERMINATI]
[Page 1.1 Announcement, dated October 20, 2016 A-1 our business objectives and strategies, including those relating to the development of our terminal procurement and distribution business; our operations and prospects; our network expansion and capital expenditure plans; the expected impact ]
[Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, October 19, 2016 -- Sabin-inactivated polio vaccine (sIPV) Varicella vaccine Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, “We are pleased ]
[Sinovac Product Pipeline News Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of biopharmaceutical products in China BEIJING, China, October 19, 2016 -- Sabin-inactivated polio vaccine (sIPV) Varicella vaccine Mr. Weidong Yin, Chairman, President and CEO of Sinovac commented, “We are pleased ]